0001845022-22-000057 | 10-Q | XBRL Viewer

Print Document View Excel Document

Cover - shares	3 Months Ended
Cover - shares	Apr. 30, 2022	May 31, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2022
Document Transition Report	false
Entity File Number	001-40601
Entity Registrant Name	Couchbase, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3576987
Entity Address, Street	3250 Olcott Street
Entity Address, City	Santa Clara
Entity Address, State	CA
Entity Address, Postal Zip Code	95054
City Area Code	650
Local Phone Number	417-7500
Title of each class	Common stock, par value $0.00001 per share
Trading Symbol(s)	BASE
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		44,551,077
Entity Central Index Key	0001845022
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Current assets
Cash and cash equivalents	$ 47,672	$ 95,688
Short-term investments	153,409	110,266
Accounts receivable, net	24,622	36,696
Deferred commissions	11,548	11,783
Prepaid expenses and other current assets	8,014	8,559
Total current assets	245,265	262,992
Property and equipment, net	4,341	4,288
Operating lease right-of-use assets	7,668	0
Deferred commissions, noncurrent	8,267	8,243
Other assets	1,453	1,219
Total assets	266,994	276,742
Current liabilities
Accounts payable	2,640	1,923
Accrued compensation and benefits	8,025	16,143
Other accrued expenses	2,946	3,231
Operating lease liabilities	2,717	0
Deferred revenue	68,466	69,010
Total current liabilities	84,794	90,307
Operating lease liabilities, noncurrent	5,627	0
Deferred revenue, noncurrent	2,289	2,713
Other liabilities	0	507
Total liabilities	92,710	93,527
Commitments and contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.00001 par value; 200,000,000 shares authorized as of April 30, 2022 and January 31, 2022; zero shares issued outstanding as of April 30, 2022 and January 31, 2022	0	0
Common stock, $0.00001 par value; 1,000,000,000 shares authorized as of April 30, 2022 and January 31, 2022; 44,537,296 and 43,847,484 shares issued and outstanding as of April 30, 2022 and January 31, 2022, respectively	0	0
Additional paid-in capital	536,981	525,392
Accumulated other comprehensive loss	(881)	(195)
Accumulated deficit	(361,816)	(341,982)
Total stockholders’ equity	174,284	183,215
Total liabilities and stockholders’ equity	$ 266,994	$ 276,742

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares	Apr. 30, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	44,537,296	43,847,484
Common stock, shares outstanding (in shares)	44,537,296	43,847,484

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Revenue:
Total revenue	$ 34,853	$ 27,955
Cost of revenue:
Total cost of revenue	4,651	3,392
Gross profit	30,202	24,563
Operating expenses:
Research and development	14,421	12,541
Sales and marketing	26,843	20,634
General and administrative	7,926	5,497
Total operating expenses	49,190	38,672
Loss from operations	(18,988)	(14,109)
Interest expense	(25)	(245)
Other income (expense), net	(556)	84
Loss before income taxes	(19,569)	(14,270)
Provision for income taxes	265	329
Net loss	(19,834)	(14,599)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(1,479)
Net loss attributable to common stockholders	(19,834)	(16,078)
Net loss attributable to common stockholders	$ (19,834)	$ (16,078)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.45)	$ (2.55)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.45)	$ (2.55)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,265,000	6,302,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,265,000	6,302,000
Subscription
Revenue:
Total revenue	$ 31,981	$ 26,465
Cost of revenue:
Total cost of revenue	2,396	2,052
Services
Revenue:
Total revenue	2,872	1,490
Cost of revenue:
Total cost of revenue	2,255	1,340
License \| Subscription
Revenue:
Total revenue	5,007	4,278
Support and other \| Subscription
Revenue:
Total revenue	$ 26,974	$ 22,187

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (19,834)	$ (14,599)
Other comprehensive income (loss):
Net unrealized gains (losses) on investments, net of tax	(686)	(2)
Total comprehensive loss	$ (20,520)	$ (14,601)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Jan. 31, 2021		$ 259,822
Beginning balance (in shares) at Jan. 31, 2021		26,070,213
Ending balance at Apr. 30, 2021		$ 259,822
Ending balance (in shares) at Apr. 30, 2021		26,070,213
Beginning balance at Jan. 31, 2021	$ (246,342)			$ 37,410	$ 1	$ (283,753)
Beginning balance (in shares) at Jan. 31, 2021			6,199,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	1,447			1,447
Issuance of common stock upon exercise of stock options (in shares)			261,563
Stock-based compensation	1,829			1,829
Net unrealized gains (losses) on investments	(2)				(2)
Net loss	(14,599)					(14,599)
Ending balance at Apr. 30, 2021	(257,667)			40,686	(1)	(298,352)
Ending balance (in shares) at Apr. 30, 2021			6,460,868
Beginning balance at Jan. 31, 2022	183,215			525,392	(195)	(341,982)
Beginning balance (in shares) at Jan. 31, 2022			43,847,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options	2,614			2,614
Issuance of common stock upon exercise of stock options (in shares)			452,313
Issuance of common stock in connection with employee stock purchase plan	3,525			3,525
Issuance of common stock in connection with employee stock purchase plan (in shares)			237,499
Stock-based compensation	5,450			5,450
Net unrealized gains (losses) on investments	(686)				(686)
Net loss	(19,834)					(19,834)
Ending balance at Apr. 30, 2022	$ 174,284			$ 536,981	$ (881)	$ (361,816)
Ending balance (in shares) at Apr. 30, 2022			44,537,296

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Cash flows from operating activities
Net loss	$ (19,834)	$ (14,599)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	739	708
Stock-based compensation	5,450	1,829
Amortization of deferred commissions	4,009	2,958
Non-cash lease expense	648	0
Foreign currency transaction (gains) losses	974	(75)
Other	198	34
Changes in operating assets and liabilities
Accounts receivable	11,781	18,557
Deferred commissions	(3,798)	(2,718)
Prepaid expenses and other assets	312	(1,898)
Accounts payable	731	1,021
Accrued compensation and benefits	(8,112)	(3,274)
Accrued expenses and other liabilities	(71)	(668)
Operating lease liabilities	(666)	0
Deferred revenue	(968)	(5,064)
Net cash used in operating activities	(8,607)	(3,189)
Cash flows from investing activities
Purchases of short-term investments	(53,630)	(1,726)
Maturities of short-term investments	9,600	5,190
Additions to property and equipment	(799)	(230)
Net cash provided by (used in) investing activities	(44,829)	3,234
Cash flows from financing activities
Proceeds from exercise of stock options	2,614	1,447
Proceeds from issuance of common stock under ESPP	3,525	0
Payments of deferred offering costs	0	(1,439)
Net cash provided by financing activities	6,139	8
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(719)	(6)
Net increase (decrease) in cash, cash equivalents and restricted cash	(48,016)	47
Cash, cash equivalents and restricted cash
Beginning of period	96,231	37,840
End of period	48,215	37,887
Cash and cash equivalents	47,672	37,344
Restricted cash included in other assets	543	543
Supplemental disclosures of cash activities
Cash paid for income taxes	275	271
Cash paid for interest	25	246
Non-cash investing and financing activities:
Net change in unrealized gains or losses on available-for-sale debt securities	(686)	(3)
Change in deferred offering costs included in accounts payable and other accrued liabilities	0	102
Change in purchases of property and equipment included in accounts payable and other accrued liabilities	$ (9)	$ (227)

Description of Business	3 Months Ended
Description of Business	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of BusinessCouchbase, Inc. provides an enterprise-class, multi-cloud NoSQL database architected on top of an open source foundation. Couchbase was incorporated in the State of Delaware in 2008 and is headquartered in Santa Clara, California. In these notes to the unaudited condensed consolidated financial statements, the “Company,” “Couchbase,” “we,” “us” and “our” refers to Couchbase, Inc. and its subsidiaries on a consolidated basis.

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission, (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2022, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three months ended April 30, 2022, are not necessarily indicative of the results to be expected for the year ending January 31, 2023, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company's Annual Report on Form 10-K for the year ended January 31, 2022, as filed with the SEC on March 31, 2022. Initial Public Offering In July 2021, the Company completed its initial public offering (“IPO”), for the sale and issuance of $9,589,999 shares of its common stock at $24.00 per share, which included 1,250,869 shares issued pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received net proceeds of $214.9 million, after deducting underwriters’ discounts and commissions and before consideration of other issuance costs. In connection with the IPO, all 26,710,600 shares of outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of common stock, inclusive of 640,387 shares of additional stock issued related to preferred stock conversion and dividend features. Reverse Stock Split On June 30, 2021, the Company effected a 2.5 -for-1 reverse stock split of its outstanding common stock, common stock warrants, preferred stock, and stock option awards. All issued and outstanding shares of common stock, common stock warrants, preferred stock, stock option awards and per share data have been adjusted in these condensed consolidated financial statements, on a retrospective basis, to reflect the reverse stock split for all periods presented. The par value of the common stock and preferred stock was not adjusted because of the reverse stock split. Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices (“SSP”) for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company's common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. COVID-19 While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements. Significant Accounting Policies Except for the accounting policy for leases, which was updated as a result of adopting a new accounting standard, there have been no material changes to the significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022. See “Recently Adopted Accounting Pronouncements” below for additional information on the impact of the adoption of the new accounting standard for leases on the Company’s consolidated financial statements. Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Intangibles—Goodwill and Other— Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this ASU. The Company adopted this guidance on February 1, 2022 prospectively for implementation costs incurred after the date of adoption, and the adoption did not have a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by amending and clarifying existing guidance in ASC 740, as well as removing certain exceptions within ASC 740. The Company adopted this guidance on February 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. Leases In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02 and several amendments, codified as ASC 842, Leases which amends the existing accounting standards for leases. The new standard requires lessees to record a right-of-use ("ROU") asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The Company adopted the guidance on February 1, 2022 utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2023. The Company elected the package of transitional practical expedients upon which, among other provisions, allowed the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs, for any existing leases on the adoption date. The Company elected not to record leases that, at the commencement date, have a lease term of 12 months or less. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing impairment of ROU assets. The Company also did not elect to combine its lease and non-lease components. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Lease ROU assets and liabilities, with the exception of short-term leases, are recognized at the commencement date based on the present value of lease payments over the lease term. The Company estimates the discount rate based on the information available at the lease commencement date unless the implicit rate is readily determinable. For leases that commenced prior to the adoption of Topic 842, the Company used the discount rate on February 1, 2022. The lease ROU assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain the extension option will be exercised. Upon adoption of ASC 842, the Company recognized operating lease ROU assets and operating lease liabilities of $6.7 million and $7.5 million, respectively, as of February 1, 2022 and did not include any retrospective adjustments to comparative periods to reflect the adoption of ASC 842. The difference of $0.8 million between operating lease ROU assets and operating lease liabilities at the adoption date related to deferred rent. See Note 8, “Leases” to the Notes to Condensed Consolidated Financial Statements for more information. Accounting Pronouncements Not Yet Adopted Under the JOBS Act, the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments

3 Months Ended

Apr. 30, 2022

Cash, Cash Equivalents, and Short-term Investments [Abstract]

Cash Equivalents and Short-Term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of April 30, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	42,651	$	—	$	—	$	42,651
Total cash equivalents	42,651		—		—		42,651
Short-Term Investments
U.S. government treasury securities	86,841		—		(735)		86,106
Commercial paper	35,784		—		(1)		35,783
Corporate debt securities	31,665		—		(145)		31,520
Total short-term investments	154,290		—		(881)		153,409
Total	$	196,941	$	—	$	(881)	$	196,060


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Commercial paper	40,966		—		(1)		40,965
Corporate debt securities	30,156		—		(66)		30,090
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

During the three months ended April 30, 2022 and 2021, the Company did not reclassify any amounts to earnings from accumulated other comprehensive income (loss) related to unrealized gains or losses in other income (expense), net in the condensed consolidated statements of operations.

As of April 30, 2022 the Company’s short-term investments consisted of $123.2 million and $30.2 million with a contractual maturity date of less than one year and greater than one year, respectively. As of January 31, 2022, the Company’s short-term investments consisted of $108.3 million and $2.0 million with a contractual maturity of less than one year and greater than one year, respectively.

As of April 30, 2022, the Company had 32 short-term investments in an unrealized loss position. These short-term investments had an estimated fair value of $118.6 million and were not in a continuous unrealized loss position for more than twelve months. As of January 31, 2022, the Company had 25 short-term investment in an unrealized loss position. This short-term investment had an estimated fair value of $71.8 million and was not in a continuous unrealized loss position for more than twelve months. During the three months ended April 30, 2022, the Company had no other-than-temporary impairments of short-term investments.

Fair Value Measurements

3 Months Ended

Apr. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

The Company accounts for certain of its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts reflected on the condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short maturities of those instruments.

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of April 30, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	42,651	$	—	$	42,651
Total cash equivalents	42,651		—		42,651
Short-Term Investments
U.S. government treasury securities	—		86,106		86,106
Commercial paper	—		35,783		35,783
Corporate debt securities	—		31,520		31,520
Total short-term investments	—		153,409		153,409
Total	$	42,651	$	153,409	$	196,060


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Commercial paper	—		40,965		40,965
Corporate debt securities	—		30,090		30,090
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

The Company classifies its money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its commercial paper, U.S. government securities, and. corporate debt securities within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

3 Months Ended

Apr. 30, 2022

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Prepaid expenses	$	3,817	$	4,518
Prepaid software	2,779		2,297
Other current assets	1,418		1,744
Total prepaid expenses and other current assets	$	8,014	$	8,559

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Computer equipment	$	3,442	$	3,711
Furniture and fixtures	427		412
Capitalized internal-use software	5,772		5,772
Leasehold improvements	1,582		1,582
Construction in progress—capitalized internal-use software	772		—
Total gross property and equipment	11,995		11,477
Accumulated depreciation and amortization	(7,654)		(7,189)
Total property and equipment, net	$	4,341	$	4,288

Depreciation and amortization expense was $0.7 million in each of the three months ended April 30, 2022 and 2021. Included in these amounts were the amortization of capitalized internal-use software development costs of $0.5 million in each of the three months ended April 30, 2022 and 2021.

Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Accrued bonus	$	2,400	$	5,557
Accrued commissions	2,546		4,226
Accrued payroll and benefits	2,515		2,863
Employee contributions under the ESPP	564		3,497
Total accrued compensation and benefits	$	8,025	$	16,143

Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Accrued professional fees	$	939	$	717
Sales and value added tax payable	408		671
Income taxes payable	372		414

Other	1,227		1,429
Total other accrued liabilities	$	2,946	$	3,231

Deferred Revenue and Remaining Performance Obligations

3 Months Ended

Apr. 30, 2022

Revenue from Contract with Customer [Abstract]

Deferred Revenue and Remaining Performance Obligations

The following table presents the deferred revenue balances (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Deferred revenue, current	$	68,466	$	69,010
Deferred revenue, noncurrent	2,289		2,713
Total deferred revenue	$	70,755	$	71,723

Changes in the deferred revenue balances during the three months ended April 30, 2022 and 2021 (unaudited) were as follows (in thousands):


	Three Months Ended April 30,
	2022		2021
Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(24,207)		(22,094)
Increases due to invoicing prior to satisfaction of performance obligations	23,239		17,032
Ending balance	$	70,755	$	56,648

Remaining performance obligations (“RPOs”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods.

As of April 30, 2022, the Company’s RPOs were $169.0 million. The Company expects to recognize revenue of $100.7 million of these remaining performance obligations over the next twelve months with the remaining balances recognized thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

+ Details

Debt	3 Months Ended
Debt	Apr. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt Interest expense consisting primarily of unused Credit Facility (as defined below) fees was immaterial for the three months ended April 30, 2022. Interest expense on the Company’s borrowings was $0.2 million for the three months ended April 30, 2021. The effective interest rate was 3.8% for the three months ended April 30, 2021. Term Loan In August 2018, the Company entered into an agreement for a term loan with a certain lender, which was amended in April 2019 and in June 2020 (the "Amended Loan"). The Amended Loan provided maximum borrowings of up to $25.0 million, maturing in June 2024. In January 2021, the Company repaid all outstanding indebtedness owed pursuant to the Amended Loan and terminated the agreement. Pursuant to the termination of the Amended Loan, the related security interests have been removed and the covenants shall be of no further force and effect. In connection with the April 2019 amendment, the Company issued warrants to purchase 105,350 shares of the Company’s common stock at $7.48 per share, exercisable over 10 years. The fair value of the warrants was recorded to equity and as a debt discount that was amortized to interest over the term of the loan. The total fair value of the common stock warrants was $0.4 million. As of April 30, 2022, all warrants were outstanding and exercisable. Credit Facility In November 2017, the Company entered into a line of credit agreement with Silicon Valley Bank, or Credit Facility, providing the Company the ability to borrow up to $10.0 million from a revolving line of credit with an original maturity date in November 2018. Borrowings under the line of credit bear interest at a floating per annum rate equal to one half of one percentage point (0.50%) above the prime rate, which interest shall be payable monthly.The line of credit is secured with a pledge on substantially all the assets of the Company, except any intellectual property and is subject to a minimum revenue covenant. In November 2018, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $15.0 million and extend the maturity date to November 2019. In April 2019, an amendment was entered into with the Silicon Valley Bank to decrease the line of credit to $10.0 million. In April 2020, an amendment was entered into with Silicon Valley Bank to extend the maturity of the line of credit to November 2020. In November 2020, the Company entered into an amendment with Silicon Valley Bank to extend the maturity of the line of credit to February 2021. In January 31, 2021, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $40.0 million and extend the maturity date to January 2024. Upon the execution of this amendment, the Company borrowed $25.0 million from the line of credit. The outstanding principal balance is due at maturity with interest payable monthly. The line of credit bears a variable annual interest rate of the prime rate plus 0.5%. The Company is required to pay a fee equal to 0.25% per annum on the unused portion of the line of credit. The Company is also subject to a termination fee ranging from 0.5% to 1% of the line of credit if the Company terminates the agreement prior to the maturity date. The amendment also added certain financial covenants, including covenants related to certain financial metrics, that if not met, would limit the amount of additional borrowings under the line of credit. The amended line of credit agreement requires the company to maintain an adjusted quick ratio (as defined by the agreement) of at least 1.15 to 1.0. The line of credit agreement also contains certain customary affirmative and negative covenants as well as customary events of default, subject to certain exceptions, including restrictions on the Company’s ability to, among other things, incur debt and liens, maintain collateral accounts, undergo fundamental changes including mergers or consolidations, dispose assets including selling, transferring or assigning assets, pay dividends or other distributions or make or permit payments on any subordinated debt. The Company was in compliance with the financial covenants under the line of credit as of April 30, 2022. The Company repaid the outstanding principal of its revolving line of credit of $25.0 million during the year ended January 31, 2022. There were no borrowings outstanding against the line of credit as of April 30, 2022. As of April 30, 2022, $40.0 million was available for borrowing under the line of credit.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

3 Months Ended

Apr. 30, 2022

Leases [Abstract]

Leases

The Company leases facilities under non-cancelable operating leases, primarily for rent of office space. Our leases have various expiration dates through November 2027, some of which include options to extend the leases for up to three years. The Company does not have any finance leases.

Operating lease costs were $0.6 million for the three months ended April 30, 2022. Variable lease costs were $0.2 million during the three months ended April 30, 2022. Short-term lease costs were $0.1 million during the three months ended April 30, 2022.

The following table presents supplemental cash flow information related to leases:


	Three months ended April 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	661
Right-of-use assets obtained in exchange for lease obligations:
Operating Leases	$	1,509

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of April 30, 2022

Operating lease right-of-use assets	$	7,668
Operating lease liabilities	$	2,717
Operating lease liabilities, noncurrent	5,627
Total operating lease liabilities	$	8,344
Weighted-Average Remaining Lease Term	3.3 years
Weighted-Average Discount Rate	3.8		%

As of April 30, 2022, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Remaining for Fiscal 2023	$	2,225
Fiscal 2024	2,911
Fiscal 2025	2,461
Fiscal 2026	680
Fiscal 2027 and thereafter	597
Total lease payments	8,874
Less: imputed interest	(530)
Total	$	8,344

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Other Contractual Commitments Other contractual commitments relate to third-party cloud infrastructure agreements and subscription arrangements. As of April 30, 2022, there were no material changes to the Company’s contractual commitments since January 31, 2022. Legal Matters From time to time, the Company may be a party to various legal matters, threatened claims, or proceedings in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and contingencies. Legal accruals are recorded when and if it is determined that a loss related to a certain matter is both probable and reasonably estimable. Indemnification Agreements In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which the Company agrees to indemnify customers, vendors, lessors and other business partners with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. Additionally, the Company entered into indemnification agreements with the Company’s directors and officers that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. As of May 31, 2022, no demands have been made upon the Company to provide indemnification under such agreements, and there are no claims that we are aware of that could reasonably be expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

Stockholders' Equity (Deficit) and Employee Incentive Plans

3 Months Ended

Apr. 30, 2022

Equity And Compensation Related Costs Share Based Payments [Abstract]

Stockholders' Equity (Deficit) and Employee Incentive Plans

Stockholders’ Equity (Deficit) and Employee Incentive Plans

Redeemable Convertible Preferred Stock

Upon the closing of the Company’s IPO, all 26,710,600 shares of redeemable convertible preferred stock were automatically converted into shares of common stock, which includes an additional 640,387 shares of redeemable convertible preferred stock. The additional shares of redeemable convertible preferred stock consisted of 162,032 shares for the Series E conversion feature and 478,355 shares for the Series G dividends. The carrying value of $259.8 million was reclassified into common stock and additional paid-in-capital. As of April 30, 2022, there were no shares of redeemable convertible preferred stock issued and outstanding.

In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors.

Common Stock

The Company’s Amended and Restated Certificate of Incorporation authorized the Company to issue 1,000,000,000 shares of common stock at a par value of $0.00001 as of April 30, 2022 and January 31, 2022. As of April 30, 2022 and January 31, 2022, approximately 44,537,296 and 43,847,484 shares of common stock were issued and outstanding, respectively.

Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. As of April 30, 2022 and January 31, 2022, no dividends had been declared.

As of April 30, 2022, the Company has reserved common stock for future issuance as follows:


			Number of Shares
Stock options outstanding			8,603,980
Restricted stock units issued and outstanding			3,956,641
Remaining shares available for issuance under the 2021 Plan			2,643,474
ESPP			1,030,975
Common stock warrants			105,350
Total			16,340,420

Stock Plans

The Company has three equity incentive plans: the 2008 Equity Incentive Plan (the “2008 Plan”), 2018 Equity Incentive Plan (the “2018 Plan”) and 2021 Equity Incentive Plan (the “2021 Plan”), collectively (the “Stock Plans”). In connection with the Company’s IPO in July 2021, the 2008 Plan and the 2018 Plan were terminated and replaced by the 2021 Plan and all shares that remained available for issuance under the 2018 Plan at that time were reserved for issuance under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will be increased by any shares of common stock subject to awards outstanding under the 2008 Plan and the 2018 Plan that expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by the Company for payment of an exercise price or for satisfying tax withholding obligations or are forfeited to or repurchased by the Company due to failure to vest.

The Company has issued stock options to employees, directors, consultants and advisors pursuant to the 2018 Plan and restricted stock units (“RSUs”) under the 2021 Plan.

Equity awards permitted under the 2021 Plan may be stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Stock option grants may be either Incentive Stock Options (“ISO”) or Non-Qualified Stock Options (“NSO”). ISO may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, consultants, and nonemployee directors. Employee stock options are granted with an exercise price no less than the fair value of the underlying common stock on the grant date. Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter.

As of April 30, 2022, there were 2.6 million shares available for grant under the 2021 Plan. The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year.

Employee Stock Purchase Plan

In July 2021, the Company established an Employee Stock Purchase Plan (“ESPP”) in which eligible employees may contribute up to 15% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of (1) the fair market value of a share of the Company’s common stock at the beginning of the offering period and (2) the fair market value of a share of the Company’s common stock on the purchase date. A participant will be permitted to purchase a maximum of shares during each offering period and no participant may purchase more than 1,000 shares during any offering period.

Except for the initial offering period, the ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering period consists of four purchase periods with the first purchase period ending on March 20, 2022, and the final purchase period ending on September 20, 2023.

The Company recognized stock-based compensation expense related to the ESPP of $0.8 million during the three months ended April 30, 2022. As of April 30, 2022, accrued ESPP employee payroll contributions of $0.6 million are included within accrued compensation and benefits in the consolidated balance sheet. ESPP payroll contributions used to purchase shares are reclassified to stockholders’ equity on the purchase date. As of April 30, 2022, $2.1 million of unrecognized stock-based compensation expense related to the ESPP is expected to be recognized over a weighted-average vesting period of 0.8 years.

During the three months ended April 30, 2022, 237,499 shares of common stock were issued under the ESPP.

Stock Options

The following table summarizes stock option activity under the Stock Plans for the three months ended April 30, 2022 (aggregate intrinsic value in thousands):


	Options Outstanding			Weighted- Average Contractual Term	Aggregate Intrinsic Value
	Number of Options	Weighted- Average Exercise Price
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(435,639)	$	5.79
Options granted	—	$	—
Options cancelled	(111,202)	$	14.54
Balances as of April 30, 2022	8,603,980	$	9.90	6.46	$	70,965
Options vested and expected to vest as of April 30, 2022	8,603,980	$	9.90	6.46	$	70,965
Options vested and exercisable as of April 30, 2022	6,063,428	$	7.50	5.65	$	60,069

No stock options were granted during the three months ended April 30, 2022. Stock options granted during the three months ended April 30, 2021 had a weighted-average grant-date fair value of $8.83 per share. The aggregate intrinsic value of options exercised during the three months ended April 30, 2022 and 2021 was $6.7 million and $3.8 million, respectively.

Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock.

The Company recognized stock-based compensation expense related to stock options of $1.7 million and $1.8 million during the three months ended April 30, 2022 and 2021, respectively. As of April 30, 2022 and January 31, 2022, there was $15.4 million and $17.7 million, respectively, of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.2 years and 2.5 years, for each period.

During the year ended January 31, 2018, in connection with services provided for recruitment, the Company granted 40,646 stock options outside of the Stock Plans to a third party. During the three months ended April 30, 2022, the recipient exercised 16,674 stock options and as of April 30, 2022, the recipient had exercised all 40,646 stock options. The related stock-based compensation expense was not material for the three months ended April 30, 2022 and 2021.

Service-Based RSUs

During the year ended January 31, 2022, the Company began granting RSUs to its employees. RSUs granted had service-based vesting conditions. The service based vesting condition for these awards is generally satisfied by rendering continuous service for four years, during which time the grants will vest with a cliff vesting period of one year and continued vesting quarterly thereafter.

The following table is a summary of RSU activity for the three months ended April 30, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	2,512,511	19.79
RSUs vested	—	—
RSUs forfeited	(53,428)	26.65
Balances as of April 30, 2022	2,742,641	$	22.13

The aggregate fair value of the RSU awards granted was $49.7 million during the three months ended April 30, 2022, which represents the fair value of the common stock on the date the service-based vesting awards were granted.

We recognized $2.4 million in stock-based compensation expense related to service vesting-based RSUs during the three months ended April 30, 2022. As of April 30, 2022, there was $57.2 million of unrecognized compensation expense related to service-based RSUs expected to be recognized over a weighted-average vesting period of 3.8 years.

Market-Based RSUs

During the quarter ended January 31, 2022, the Board of Directors granted 1,214,000 restricted stock unit awards with market-based vesting conditions (“Market-based RSUs”) to certain executive officers and members of senior management pursuant to the 2021 Plan. The Market-based RSUs are comprised of four tranches that vest depending on a consecutive 60-trading day stock price target of the Company’s common stock. The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	January 31, 2022
Expected term (in years)	5.0
Volatility	50.0	%
Risk-free interest rate	1.7	%
Dividend yield	—

The fair value of the Market-based RSUs was estimated at $7.9 million and segregated into four tranches with a weighted-average expense recognition period of 3.6 years.

Stock-based compensation expense related to Market-based RSUs was $0.6 million during the during the three months ended April 30, 2022. As of April 30, 2022, there was $7.3 million of unrecognized compensation expense related to Market-based RSUs expected to be recognized over an average vesting period of 3.3 years.

Determination of Fair Value

The Company estimates the fair value of stock options and purchase rights issued to employees under the ESPP using the Black-Scholes option-pricing model, which is dependent upon several variables, such as the fair value of the Company’s common stock, the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, and expected dividend yield.

Expected term—The expected term represents the weighted-average period the stock options are expected to remain outstanding and is calculated using the simplified method, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the expected term as the midpoint between the vesting date and the contractual expiration date of the option.

Expected volatility—The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company’s common stock.

Risk-free interest rate—The risk-free rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s awards.

Dividend yield—The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Fair value of underlying common stock— Prior to the Company’s IPO, the fair value was determined by the Board of Directors with input from management and contemporaneous independent third-party valuations. Subsequent to the IPO, the fair value of the Company’s common stock is based on the daily average selling price on the Nasdaq Global Select Market.

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Three Months Ended April 30,
	2022	2021
Stock Option Plans:
Expected term (in years)	*	6.1
Expected volatility	*	41.9	%
Risk-free interest rate	*	1.0	%
Dividend yield	*	—

*No stock options were granted during the three months ended April 30, 2022.

The fair value of employee stock purchase rights for the initial offering period under the 2021 ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:


			Three Months Ended April 30, 2022
Employee Stock Purchase Plan:
Expected term (in years)			1.1 - 2.1
Expected volatility			46.7% - 52.1%
Risk-free interest rate			0.1% - 0.2%
Dividend yield			—

Stock-Based Compensation

Stock-based compensation expense was as follows (in thousands):


	Three Months Ended April 30,
	2022		2021
Cost of revenue—subscription	$	122	$	27
Cost of revenue—services	94		22
Research and development	1,899		570
Sales and marketing	1,987		541
General and administrative	1,348		669
Total stock-based compensation expense	$	5,450	$	1,829

Income Taxes	3 Months Ended
Income Taxes	Apr. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and records a cumulative adjustment in such period. The Company recorded income tax expense of $0.3 million for each of the three months ended April 30, 2022 and 2021. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, capitalized research and development, and other book versus tax differences was maintained.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Geographic Information

3 Months Ended

Apr. 30, 2022

Segment Reporting [Abstract]

Geographic Information

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Three Months Ended April 30,
	2022		2021
United States	$	21,336	$	18,047
International	13,517		9,908
Total	$	34,853	$	27,955

No individual foreign country contributed 10% or more of total revenue for the three months ended April 30, 2022 and 2021.

As of April 30, 2022 and January 31, 2022, substantially all of the Company’s long-lived assets, including operating lease ROU assets, were located in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Net Loss per Share

3 Months Ended

Apr. 30, 2022

Earnings Per Share [Abstract]

Net Loss per Share

Basic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all years presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented.

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended April 30,
	2022		2021
Numerator
Net loss	$	(19,834)	$	(14,599)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(1,479)
Net loss attributable to common stockholders	$	(19,834)	$	(16,078)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,265		6,302
Net loss per share attributable to common stockholders, basic and diluted	$	(0.45)	$	(2.55)

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands):


	As of April 30,
	2022	2021
Stock options	8,604	10,131
RSUs	3,957	—
Employee stock purchase rights under the ESPP	138	—
Common stock warrants	105	105
Redeemable convertible preferred stock (on an if-converted basis)	—	26,612
Total	12,804	36,848

Subsequent Event	3 Months Ended
Subsequent Event	Apr. 30, 2022
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventIn May 2022, the Company entered into an operating lease of office space in London (the "London Lease"). The total lease payments from the commencement date are approximately $1.2 million. The London Lease expires in August 2025.

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission, (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2022, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three months ended April 30, 2022, are not necessarily indicative of the results to be expected for the year ending January 31, 2023, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company's Annual Report on Form 10-K for the year ended January 31, 2022, as filed with the SEC on March 31, 2022.
Fiscal Year	Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices (“SSP”) for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company's common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. COVID-19 While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Intangibles—Goodwill and Other— Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this ASU. The Company adopted this guidance on February 1, 2022 prospectively for implementation costs incurred after the date of adoption, and the adoption did not have a material impact on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by amending and clarifying existing guidance in ASC 740, as well as removing certain exceptions within ASC 740. The Company adopted this guidance on February 1, 2022, and the adoption did not have a material impact on its consolidated financial statements. Leases In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02 and several amendments, codified as ASC 842, Leases which amends the existing accounting standards for leases. The new standard requires lessees to record a right-of-use ("ROU") asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The Company adopted the guidance on February 1, 2022 utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2023. The Company elected the package of transitional practical expedients upon which, among other provisions, allowed the Company not to reassess under the new standard prior conclusions about lease identification, lease classification and initial direct costs, for any existing leases on the adoption date. The Company elected not to record leases that, at the commencement date, have a lease term of 12 months or less. The Company did not elect to apply the hindsight practical expedient when determining lease term and assessing impairment of ROU assets. The Company also did not elect to combine its lease and non-lease components. Non-lease components that are not fixed are expensed as incurred as variable lease payments. Lease ROU assets and liabilities, with the exception of short-term leases, are recognized at the commencement date based on the present value of lease payments over the lease term. The Company estimates the discount rate based on the information available at the lease commencement date unless the implicit rate is readily determinable. For leases that commenced prior to the adoption of Topic 842, the Company used the discount rate on February 1, 2022. The lease ROU assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend the lease term are included in the lease term when it is reasonably certain the extension option will be exercised. Upon adoption of ASC 842, the Company recognized operating lease ROU assets and operating lease liabilities of $6.7 million and $7.5 million, respectively, as of February 1, 2022 and did not include any retrospective adjustments to comparative periods to reflect the adoption of ASC 842. The difference of $0.8 million between operating lease ROU assets and operating lease liabilities at the adoption date related to deferred rent. See Note 8, “Leases” to the Notes to Condensed Consolidated Financial Statements for more information. Accounting Pronouncements Not Yet Adopted Under the JOBS Act, the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments (Tables)

3 Months Ended

Apr. 30, 2022

Cash, Cash Equivalents, and Short-term Investments [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):


	As of April 30, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	42,651	$	—	$	—	$	42,651
Total cash equivalents	42,651		—		—		42,651
Short-Term Investments
U.S. government treasury securities	86,841		—		(735)		86,106
Commercial paper	35,784		—		(1)		35,783
Corporate debt securities	31,665		—		(145)		31,520
Total short-term investments	154,290		—		(881)		153,409
Total	$	196,941	$	—	$	(881)	$	196,060


	As of January 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash Equivalents
Money market funds	$	86,505	$	—	$	—	$	86,505
Total cash equivalents	86,505		—		—		86,505
Short-Term Investments
U.S. government treasury securities	39,340		—		(129)		39,211
Commercial paper	40,966		—		(1)		40,965
Corporate debt securities	30,156		—		(66)		30,090
Total short-term investments	110,462		—		(196)		110,266
Total	$	196,967	$	—	$	(196)	$	196,771

Fair Value Measurements (Tables)

3 Months Ended

Apr. 30, 2022

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):


	As of April 30, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	42,651	$	—	$	42,651
Total cash equivalents	42,651		—		42,651
Short-Term Investments
U.S. government treasury securities	—		86,106		86,106
Commercial paper	—		35,783		35,783
Corporate debt securities	—		31,520		31,520
Total short-term investments	—		153,409		153,409
Total	$	42,651	$	153,409	$	196,060


	As of January 31, 2022
	Level 1		Level 2		Total
Cash Equivalents
Money market funds	$	86,505	$	—	$	86,505
Total cash equivalents	86,505		—		86,505
Short-Term Investments
U.S. government treasury securities	—		39,211		39,211
Commercial paper	—		40,965		40,965
Corporate debt securities	—		30,090		30,090
Total short-term investments	—		110,266		110,266
Total	$	86,505	$	110,266	$	196,771

Balance Sheet Components (Tables)

3 Months Ended

Apr. 30, 2022

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Prepaid expenses	$	3,817	$	4,518
Prepaid software	2,779		2,297
Other current assets	1,418		1,744
Total prepaid expenses and other current assets	$	8,014	$	8,559

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Computer equipment	$	3,442	$	3,711
Furniture and fixtures	427		412
Capitalized internal-use software	5,772		5,772
Leasehold improvements	1,582		1,582
Construction in progress—capitalized internal-use software	772		—
Total gross property and equipment	11,995		11,477
Accumulated depreciation and amortization	(7,654)		(7,189)
Total property and equipment, net	$	4,341	$	4,288

Schedule of Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Accrued bonus	$	2,400	$	5,557
Accrued commissions	2,546		4,226
Accrued payroll and benefits	2,515		2,863
Employee contributions under the ESPP	564		3,497
Total accrued compensation and benefits	$	8,025	$	16,143

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Accrued professional fees	$	939	$	717
Sales and value added tax payable	408		671
Income taxes payable	372		414

Other	1,227		1,429
Total other accrued liabilities	$	2,946	$	3,231

Deferred Revenue and Remaining Performance Obligations (Tables)

3 Months Ended

Apr. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Deferred Revenue Balances and Changes in Deferred Revenues Balances

The following table presents the deferred revenue balances (in thousands):


	As of April 30,		As of January 31,
	2022		2022
Deferred revenue, current	$	68,466	$	69,010
Deferred revenue, noncurrent	2,289		2,713
Total deferred revenue	$	70,755	$	71,723

Changes in the deferred revenue balances during the three months ended April 30, 2022 and 2021 (unaudited) were as follows (in thousands):


	Three Months Ended April 30,
	2022		2021
Beginning balance	$	71,723	$	61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(24,207)		(22,094)
Increases due to invoicing prior to satisfaction of performance obligations	23,239		17,032
Ending balance	$	70,755	$	56,648

Leases (Tables)

3 Months Ended

Apr. 30, 2022

Leases [Abstract]

Schedule of Supplemental Cash Flow Related to Leases

The following table presents supplemental cash flow information related to leases:


	Three months ended April 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	661
Right-of-use assets obtained in exchange for lease obligations:
Operating Leases	$	1,509

Schedule of Supplemental Balance Sheet Information

The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate):


	As of April 30, 2022

Operating lease right-of-use assets	$	7,668
Operating lease liabilities	$	2,717
Operating lease liabilities, noncurrent	5,627
Total operating lease liabilities	$	8,344
Weighted-Average Remaining Lease Term	3.3 years
Weighted-Average Discount Rate	3.8		%

Schedule of Operating Lease Maturities

As of April 30, 2022, remaining maturities of operating lease liabilities were as follows (in thousands):


Period	Operating Leases
Remaining for Fiscal 2023	$	2,225
Fiscal 2024	2,911
Fiscal 2025	2,461
Fiscal 2026	680
Fiscal 2027 and thereafter	597
Total lease payments	8,874
Less: imputed interest	(530)
Total	$	8,344

Schedule of Future Minimum Rental Payments for Operating Leases

Future minimum lease payments under non-cancelable operating leases as of January 31, 2022 under ASC 840 were as follows (in thousands):


Year Ending January 31,	Operating Leases
2023	$	2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	—
Total	$	8,023

Stockholders' Equity (Deficit) and Employee Incentive Plans (Tables)

3 Months Ended

Apr. 30, 2022

Equity And Compensation Related Costs Share Based Payments [Abstract]

Schedule of Reserved Common Stock for Future Issuance

As of April 30, 2022, the Company has reserved common stock for future issuance as follows:


			Number of Shares
Stock options outstanding			8,603,980
Restricted stock units issued and outstanding			3,956,641
Remaining shares available for issuance under the 2021 Plan			2,643,474
ESPP			1,030,975
Common stock warrants			105,350
Total			16,340,420

Schedule of Stock Option Activity under Stock Plans

The following table summarizes stock option activity under the Stock Plans for the three months ended April 30, 2022 (aggregate intrinsic value in thousands):


	Options Outstanding			Weighted- Average Contractual Term	Aggregate Intrinsic Value
	Number of Options	Weighted- Average Exercise Price
Balances as of January 31, 2022	9,150,821	$	9.76	6.53	$	126,368
Options exercised	(435,639)	$	5.79
Options granted	—	$	—
Options cancelled	(111,202)	$	14.54
Balances as of April 30, 2022	8,603,980	$	9.90	6.46	$	70,965
Options vested and expected to vest as of April 30, 2022	8,603,980	$	9.90	6.46	$	70,965
Options vested and exercisable as of April 30, 2022	6,063,428	$	7.50	5.65	$	60,069

Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity

The following table is a summary of RSU activity for the three months ended April 30, 2022:


	RSUs Outstanding
	Number of RSUs	Weighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022	283,558	$	43.76
RSUs granted	2,512,511	19.79
RSUs vested	—	—
RSUs forfeited	(53,428)	26.65
Balances as of April 30, 2022	2,742,641	$	22.13

Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions

The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:


	January 31, 2022
Expected term (in years)	5.0
Volatility	50.0	%
Risk-free interest rate	1.7	%
Dividend yield	—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of employee stock options was estimated using the following weighted-average assumptions:


	Three Months Ended April 30,
	2022	2021
Stock Option Plans:
Expected term (in years)	*	6.1
Expected volatility	*	41.9	%
Risk-free interest rate	*	1.0	%
Dividend yield	*	—

*No stock options were granted during the three months ended April 30, 2022.

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions


			Three Months Ended April 30, 2022
Employee Stock Purchase Plan:
Expected term (in years)			1.1 - 2.1
Expected volatility			46.7% - 52.1%
Risk-free interest rate			0.1% - 0.2%
Dividend yield			—

Schedule of Stock-Based Compensation Expense

Stock-Based Compensation

Stock-based compensation expense was as follows (in thousands):


	Three Months Ended April 30,
	2022		2021
Cost of revenue—subscription	$	122	$	27
Cost of revenue—services	94		22
Research and development	1,899		570
Sales and marketing	1,987		541
General and administrative	1,348		669
Total stock-based compensation expense	$	5,450	$	1,829

Geographic Information (Tables)

3 Months Ended

Apr. 30, 2022

Segment Reporting [Abstract]

Schedule of Disaggregation of Revenue by Geographic Area

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):


	Three Months Ended April 30,
	2022		2021
United States	$	21,336	$	18,047
International	13,517		9,908
Total	$	34,853	$	27,955

Net Loss per Share (Tables)

3 Months Ended

Apr. 30, 2022

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended April 30,
	2022		2021
Numerator
Net loss	$	(19,834)	$	(14,599)
Cumulative dividends on Series G redeemable convertible preferred stock	—		(1,479)
Net loss attributable to common stockholders	$	(19,834)	$	(16,078)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	44,265		6,302
Net loss per share attributable to common stockholders, basic and diluted	$	(0.45)	$	(2.55)

Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share


	As of April 30,
	2022	2021
Stock options	8,604	10,131
RSUs	3,957	—
Employee stock purchase rights under the ESPP	138	—
Common stock warrants	105	105
Redeemable convertible preferred stock (on an if-converted basis)	—	26,612
Total	12,804	36,848

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	Jul. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021	Apr. 30, 2022 USD ($) shares	Feb. 01, 2022 USD ($)	Jan. 31, 2022 USD ($)
Basis Of Presentation And Summary Of Significant Accounting Policies
Consideration received on transaction \| $	$ 214,900
Conversion of convertible securities (in shares)	26,710,600
Preferred stock and dividend features converted into common stock (in shares)	640,387
Operating lease right-of-use assets \| $			$ 7,668	$ 6,700	$ 0
Total operating lease liabilities \| $			$ 8,344	7,500
Deferred rent credit \| $				$ 800
Common Stock
Basis Of Presentation And Summary Of Significant Accounting Policies
Reverse stock split of outstanding common stock		2.5
IPO
Basis Of Presentation And Summary Of Significant Accounting Policies
Number of common stock for sale and issuance (in shares)	9,589,999		0
Common stock public offering price per share (in dollar per share) \| $ / shares	$ 24.00
Conversion of convertible securities (in shares)	26,710,600
Underwriters Option to Purchase Additional Shares
Basis Of Presentation And Summary Of Significant Accounting Policies
Number of common stock for sale and issuance (in shares)	1,250,869

Cash Equivalents and Short-Term Investments - Summary of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash Equivalents	$ 42,651	$ 86,505
Estimated Fair Value	42,651	86,505
Cash and Cash Equivalents and Short-Term Investments, Amortized Cost	196,941	196,967
Cash and Cash Equivalents and Short Term Investments Estimated Fair Value	196,060	196,771
Short-Term Investments, Amortized Cost	154,290	110,462
Short-Term Investments, Gross Unrealized Gains	0	0
Short-Term Investments, Gross Unrealized Losses	(881)	(196)
Short-Term Investments, Estimated Fair Value	153,409	110,266
U.S. government treasury securities
Schedule Of Cash Cash Equivalents And Short Term Investments
Short-Term Investments, Amortized Cost	86,841	39,340
Short-Term Investments, Gross Unrealized Gains	0	0
Short-Term Investments, Gross Unrealized Losses	(735)	(129)
Short-Term Investments, Estimated Fair Value	86,106	39,211
Commercial paper
Schedule Of Cash Cash Equivalents And Short Term Investments
Short-Term Investments, Amortized Cost	35,784	40,966
Short-Term Investments, Gross Unrealized Gains	0	0
Short-Term Investments, Gross Unrealized Losses	(1)	(1)
Short-Term Investments, Estimated Fair Value	35,783	40,965
Corporate debt securities
Schedule Of Cash Cash Equivalents And Short Term Investments
Short-Term Investments, Amortized Cost	31,665	30,156
Short-Term Investments, Gross Unrealized Gains	0	0
Short-Term Investments, Gross Unrealized Losses	(145)	(66)
Short-Term Investments, Estimated Fair Value	31,520	30,090
Money market funds
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash Equivalents	42,651	86,505
Estimated Fair Value	$ 42,651	$ 86,505

Cash Equivalents and Short Term Investments - Additional Information (Details)	3 Months Ended		12 Months Ended
	Apr. 30, 2022 USD ($) investment	Apr. 30, 2021 USD ($)	Jan. 31, 2022 USD ($) investment
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Reclassify from accumulated other comprehensive income (loss)	$ 0	$ 0
Contractual maturity in one year	123,200,000		$ 108,300,000
Contractual maturity greater than one year	$ 30,200,000		$ 2,000,000
Number of short-term investments in unrealized loss position \| Investment \| investment	32		25
Short-term investments estimated fair value	$ 118,600,000		$ 71,800,000
Other than temporary impairment losses investments	$ 0
Less Than Year One
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Short term investments contractual maturity date	1 year		1 year
Greater Than Year One
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Short term investments contractual maturity date	1 year		1 year

Fair Value Measurements - Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 42,651	$ 86,505
Total short-term investments	153,409	110,266
U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	86,106	39,211
Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	35,783	40,965
Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	31,520	30,090
Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,651	86,505
Fair Value, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,651	86,505
Total short-term investments	153,409	110,266
Total	196,060	196,771
Fair Value, Recurring \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	86,106	39,211
Fair Value, Recurring \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	35,783	40,965
Fair Value, Recurring \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	31,520	30,090
Fair Value, Recurring \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,651	86,505
Total short-term investments	0	0
Total	42,651	86,505
Fair Value, Recurring \| Level 1 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Total short-term investments	153,409	110,266
Total	153,409	110,266
Fair Value, Recurring \| Level 2 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	86,106	39,211
Fair Value, Recurring \| Level 2 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	35,783	40,965
Fair Value, Recurring \| Level 2 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	31,520	30,090
Fair Value, Recurring \| Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,651	86,505
Fair Value, Recurring \| Money market funds \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	42,651	86,505
Fair Value, Recurring \| Money market funds \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 0	$ 0

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 3,817	$ 4,518
Prepaid software	2,779	2,297
Other current assets	1,418	1,744
Total prepaid expenses and other current assets	$ 8,014	$ 8,559

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Property Plant And Equipment [Line Items]
Total gross property and equipment	$ 11,995	$ 11,477
Accumulated depreciation and amortization	(7,654)	(7,189)
Total property and equipment, net	4,341	4,288
Computer equipment
Property Plant And Equipment [Line Items]
Total gross property and equipment	3,442	3,711
Furniture and fixtures
Property Plant And Equipment [Line Items]
Total gross property and equipment	427	412
Capitalized internal-use software
Property Plant And Equipment [Line Items]
Total gross property and equipment	5,772	5,772
Leasehold improvements
Property Plant And Equipment [Line Items]
Total gross property and equipment	1,582	1,582
Construction in progress—capitalized internal-use software
Property Plant And Equipment [Line Items]
Total gross property and equipment	$ 772	$ 0

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Property Plant And Equipment [Line Items]
Depreciation and amortization	$ 739	$ 708
Capitalized internal-use software
Property Plant And Equipment [Line Items]
Depreciation and amortization	$ 500	$ 500

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Accrued Compensation and Benefits
Accrued bonus	$ 2,400	$ 5,557
Accrued commissions	2,546	4,226
Accrued payroll and benefits	2,515	2,863
Employee contributions under the ESPP	564	3,497
Total accrued compensation and benefits	$ 8,025	$ 16,143

Balance Sheet Components - Schedule of Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022
Other Accrued Liabilities
Accrued professional fees	$ 939	$ 717
Sales and value added tax payable	408	671
Income taxes payable	372	414
Other	1,227	1,429
Total other accrued liabilities	$ 2,946	$ 3,231

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Jan. 31, 2022	Apr. 30, 2021	Jan. 31, 2021
Contract with Customer, Liability [Abstract]
Deferred revenue, current	$ 68,466	$ 69,010
Deferred revenue, noncurrent	2,289	2,713
Total deferred revenue	$ 70,755	$ 71,723	$ 56,648	$ 61,710

Deferred Revenue and Remaining Performance Obligations - Schedule of Changes In Deferred Revenue Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Change In Contract With Customer, Liability [Roll Forward]
Beginning balance	$ 71,723	$ 61,710
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(24,207)	(22,094)
Increases due to invoicing prior to satisfaction of performance obligations	23,239	17,032
Ending balance	$ 70,755	$ 56,648

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) $ in Millions	Apr. 30, 2022 USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 169.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-05-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 100.7
Revenue expected to be recognized from remaining performance obligations, period (in months)	12 months

Debt - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended
Debt - Additional Information (Details) - USD ($)	Jan. 31, 2021	Nov. 30, 2017	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022	Jun. 30, 2020	Apr. 30, 2019	Nov. 30, 2018
Debt Instrument
Interest expense, debt			$ 0	$ 200,000
Effective interest rate (as a percent)				3.80%
Fair value of common stock							$ 400,000
Credit Facility
Debt Instrument
Maximum borrowing capacity	$ 40,000,000	$ 10,000,000					$ 10,000,000	$ 15,000,000
Borrowed line of credit	$ 25,000,000
Fee payable on unused portion of line of credit (as a percent)	0.25%
Line of credit facility adjusted quick ratio	1.15
Repayment of outstanding principal amount					$ 25,000,000
Line of credit outstanding			0
Current borrowing capacity			$ 40,000,000
Minimum \| Credit Facility
Debt Instrument
Line of credit facility termination fee (as a percent)	0.50%
Maximum \| Credit Facility
Debt Instrument
Line of credit facility termination fee (as a percent)	1.00%
Prime Rate \| Credit Facility
Debt Instrument
Variable rate (as a percent)	0.50%	0.50%
Loans Payable \| Amended Loan
Debt Instrument
Maximum borrowing capacity						$ 25,000,000
Warrants issued to purchase common stock (in shares)							105,350
Exercise price of warrants or rights (in dollars per share)							$ 7.48
Warrants exercisable period (in years)							10 years

Leases - Narrative (Details) $ in Millions	3 Months Ended
Leases - Narrative (Details) $ in Millions	Apr. 30, 2022 USD ($)
Lessee, Lease, Description
Operating lease cost	$ 0.6
Variable lease cost	0.2
Short-term lease cost	$ 0.1
Maximum
Lessee, Lease, Description
Lease term (up to) (in years)	3 years

Leases - Schedule of cash flow information related to operating lease (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2022 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 661
Right-of-use assets obtained in exchange for lease obligations:
Operating Leases	$ 1,509

Leases - Schedule of balance sheet information related to operating lease (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Feb. 01, 2022	Jan. 31, 2022
Operating Lease, Assets And Liabilities, Lessee [Abstract]
Operating lease right-of-use assets	$ 7,668	$ 6,700	$ 0
Operating lease liabilities	2,717		0
Operating lease liabilities, noncurrent	5,627		$ 0
Total operating lease liabilities	$ 8,344	$ 7,500
Weighted-Average Remaining Lease Term	3 years 3 months 18 days
Weighted-Average Discount Rate	3.80%

Leases - Maturities of lease liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2022	Feb. 01, 2022
Operating Leases
Remaining for Fiscal 2023	$ 2,225
Fiscal 2024	2,911
Fiscal 2025	2,461
Fiscal 2026	680
Fiscal 2027 and thereafter	597
Total lease payments	8,874
Less: imputed interest	(530)
Total operating lease liabilities	$ 8,344	$ 7,500

Leases - Future minimum lease payments (Details) $ in Thousands	Jan. 31, 2022 USD ($)
Operating Leases
2023	$ 2,845
2024	2,638
2025	2,178
2026	362
2027 and thereafter	0
Total	$ 8,023

Stockholders' Equity (Deficit) and Employee Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended			6 Months Ended	12 Months Ended
	Mar. 20, 2022 purchasePeriod	Jul. 31, 2021 USD ($) participant $ / shares shares	Apr. 30, 2022 USD ($) vote $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares	Apr. 30, 2021 USD ($)	Sep. 21, 2021	Jan. 31, 2022 USD ($) $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award
Conversion of convertible securities (in shares)		26,710,600
Common stock, shares authorized (in shares)			1,000,000,000	1,000,000,000			1,000,000,000
Common stock, par value (in dollars per share) \| $ / shares			$ 0.00001	$ 0.00001			$ 0.00001
Common stock, shares outstanding (in shares)			44,537,296	43,847,484			43,847,484
Common stock, shares issued (in shares)			44,537,296	43,847,484			43,847,484
Number of vote \| vote			1
Dividend declared (in dollars per share) \| $ / shares			$ 0				$ 0
Number of shares reserved common stock for future issuance (in shares)			16,340,420
Initial offering period duration (in months)						24 months
Initial offering number of purchase periods \| purchasePeriod	4
Total stock-based compensation expense \| $			$ 5,450		$ 1,829
Stock-based compensation \| $			$ 5,450		1,829
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Number of shares reserved common stock for future issuance (in shares)			8,603,980
Total stock-based compensation expense \| $			$ 1,700		1,800
Unrecognized stock-based compensation expense related to unvested stock options \| $			$ 15,400	$ 17,700			$ 17,700
Stock-based compensation expected to be recognized weighted-average period (in years)			2 years 2 months 12 days				2 years 6 months
Options granted (in shares)			0
Option granted Weighted-average grant-date fair value (in dollars per share) \| $ / shares			$ 8.83
Aggregate intrinsic value of options exercised \| $			$ 6,700		$ 3,800
Issuance of common stock upon exercise of stock options (in shares)			435,639
Stock options outstanding \| Third Party
Share Based Compensation Arrangement By Share Based Payment Award
Options granted (in shares)			40,646
Issuance of common stock upon exercise of stock options (in shares)			16,674
Service-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation vesting period (in years)							1 year
Total stock-based compensation expense \| $			$ 2,400
Stock-based compensation expected to be recognized weighted-average period (in years)			3 years 9 months 18 days
Award requisite service period (in years)							4 years
Aggregate fair value of RSU granted \| $			$ 49,700
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $			$ 57,200
Market-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Stock-based compensation expected to be recognized weighted-average period (in years)			3 years 3 months 18 days	3 years 7 months 6 days
Aggregate fair value of RSU granted \| $				$ 7,900
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $			$ 7,300
RSU granted (in shares)				1,214,000			1,214,000
Stock-based compensation \| $			$ 600
2021 Plan
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation granted expiration period (in years)			10 years
Share-based compensation vesting period (in years)			4 years
Share-based compensation available for grant (in shares)			2,600,000
Number of shares reserved common stock for future issuance (in shares)			4,120,000
Share-based compensation percentage of outstanding stock (as a percent)			5.00%
2021 Plan \| First Anniversary
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation vesting rights (as a percent)			25.00%
ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Employee maximum contribution (as a percent)		15.00%
Discount rate on market value of share (as a percent)		85.00%
Number of participant may purchase more than 1000 shares \| participant		0
Total stock-based compensation expense \| $			$ 800
Employee contributions under the ESPP \| $			600
Unrecognized stock-based compensation expense related to unvested stock options \| $			$ 2,100
Stock-based compensation expected to be recognized weighted-average period (in years)			9 months 18 days
Share purchases related to ESPP (in shares)			237,499
IPO
Share Based Compensation Arrangement By Share Based Payment Award
Conversion of convertible securities (in shares)		26,710,600
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)		640,387
Number of shares outstanding (in shares)			0
Number of common stock for sale and issuance (in shares)		9,589,999	0
Redeemable convertible preferred stock, shares authorized (in shares)		200,000,000
Redeemable convertible preferred stock , par value (in dollars per share) \| $ / shares		$ 0.00001
IPO \| Series E
Share Based Compensation Arrangement By Share Based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)		162,032
Redeemable convertible preferred stock carrying amount \| $		$ 259,800
IPO \| Series G
Share Based Compensation Arrangement By Share Based Payment Award
Additional redeemable convertible preferred stock converted into shares of common stock (in shares)		478,355

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Reserved Common Stock for Future Issuance (Details)	Apr. 30, 2022 shares
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	16,340,420
Stock options outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	8,603,980
Restricted stock units issued and outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	3,956,641
Remaining shares available for issuance under the 2021 Plan
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	2,643,474
ESPP
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	1,030,975
Common stock warrants
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	105,350

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock Option Activity under Stock Plans (Details) - Stock options outstanding - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2022	Jan. 31, 2022
Options Outstanding, Number of Options
Beginning balance (in shares)	9,150,821
Options exercised (in shares)	(435,639)
Options granted (in shares)	0
Options cancelled (in shares)	(111,202)
Ending balance (in shares)	8,603,980	9,150,821
Options vested and expected to vest (in shares)	8,603,980
Options vested and exercisable (in shares)	6,063,428
Options Outstanding, Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 9.76
Options exercised (in dollars per share)	5.79
Options granted (in dollars per share)	0
Options cancelled (in dollars per share)	14.54
Ending balance (in dollars per share)	9.90	$ 9.76
Options vested and expected to vest (in dollars per share)	9.90
Options vested and exercisable (in dollars per share)	$ 7.50
Stock Options Additional Disclosures
Options outstanding, weighted average remaining contractual term (in years)	6 years 5 months 15 days	6 years 6 months 10 days
Options vested and expected to vest, weighted-average contractual term (in years)	6 years 5 months 15 days
Options vested and exercisable, weighted-average contractual term (in years)	5 years 7 months 24 days
Options outstanding, aggregate intrinsic value	$ 70,965	$ 126,368
Options vested and expected to vest, aggregate intrinsic value	70,965
Options vested and exercisable, aggregate intrinsic value	$ 60,069

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of RSU Activity (Details)	3 Months Ended
	Apr. 30, 2022 $ / shares shares
RSUs Outstanding, Number of RSUs
Beginning balance (in shares) \| shares	283,558
RSUs granted (in shares) \| shares	2,512,511
RSUs vested (in shares) \| shares	0
RSUs forfeited (in shares) \| shares	(53,428)
Ending balance (in shares) \| shares	2,742,641
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 43.76
RSUs granted (in dollars per share) \| $ / shares	19.79
RSUs vested (in dollars per share) \| $ / shares	0
RSUs forfeited (in dollars per share) \| $ / shares	26.65
Ending balance (in dollars per share) \| $ / shares	$ 22.13

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Fair Value of Employee Stock Options Estimated using Weighted-average Assumptions (Details) - shares	3 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Jan. 31, 2022
Market-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)			5 years
Volatility			50.00%
Risk-free interest rate			1.70%
Dividend yield			0.00%
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)		6 years 1 month 6 days
Volatility		41.90%
Risk-free interest rate		1.00%
Dividend yield		0.00%
Options granted (in shares)	0

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Weighted-Average Assumptions Used In Estimating Fair Value of Employee Stock Purchase Rights (Details) - 2021 ESPP	3 Months Ended
	Apr. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award
Expected volatility, minimum (as a percent)	46.70%
Expected volatility, maximum (as a percent)	52.10%
Risk-free interest rate, minimum (as a percent)	0.10%
Risk-free interest rate, maximum (as a percent)	0.20%
Dividend yield	0.00%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	1 year 1 month 6 days
Maximum
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	2 years 1 month 6 days

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 5,450	$ 1,829
Research and development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	1,899	570
Sales and marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	1,987	541
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	1,348	669
Subscription
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	122	27
Cost of Revenue - Services
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 94	$ 22

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 265	$ 329

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Geographic Information - Schedule of Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Segment Reporting Information [Line Items]
Total revenue	$ 34,853	$ 27,955
United States
Segment Reporting Information [Line Items]
Total revenue	21,336	18,047
International
Segment Reporting Information [Line Items]
Total revenue	$ 13,517	$ 9,908

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Numerator
Net loss	$ (19,834)	$ (14,599)
Cumulative dividends on Series G redeemable convertible preferred stock	0	(1,479)
Net loss attributable to common stockholders	(19,834)	(16,078)
Net loss attributable to common stockholders	$ (19,834)	$ (16,078)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	44,265,000	6,302,000
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	44,265,000	6,302,000
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.45)	$ (2.55)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.45)	$ (2.55)

Net Loss per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	12,804	36,848
Stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	8,604	10,131
RSUs
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	3,957	0
Employee stock purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	138	0
Common stock warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	105	105
Redeemable convertible preferred stock (on an if-converted basis)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	0	26,612

Subsequent Event (Details) - USD ($) $ in Thousands	May 31, 2022	Apr. 30, 2022	Feb. 01, 2022
Subsequent Event [Line Items]
Total operating lease liabilities		$ 8,344	$ 7,500
Office Space In London \| Subsequent Event
Subsequent Event [Line Items]
Total operating lease liabilities	$ 1,200